Cargando…

Identify glioma recurrence and treatment effects with triple-tracer PET/CT

BACKGROUND: Differential diagnosis of tumour recurrence (TuR) from treatment effects (TrE), mostly induced by radiotherapy and chemotherapy, is still difficult by using conventional computed tomography (CT) or magnetic resonance (MR) imaging. We have investigated the diagnostic performance of PET/CT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Cong, Yi, Chang, Chen, Yingshen, Xi, Shaoyan, Guo, Chengcheng, Yang, Qunying, Wang, Jian, Sai, Ke, Zhang, Ji, Ke, Chao, Chen, Fanfan, Lv, Yanchun, Zhang, Xiangsong, Chen, Zhongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165792/ https://www.ncbi.nlm.nih.gov/pubmed/34059015 http://dx.doi.org/10.1186/s12880-021-00624-1

Ejemplares similares

Clinical significance of histopathological features of paired recurrent gliomas: a cohort study from a single cancer center
por: Li, Cong, et al.
Publicado: (2023)

TIPS-05 ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY FOLLOWING RADIOTHERAPY IN NEWLY DIAGNOSED LOW-GRADE GLIOMA PATIENT WITH RESIDUE TUMORS: A MULTICENTER, OPEN LABEL, RANDOMIZED TRIAL
por: Chen, Zhongping, et al.
Publicado: (2023)

SYST-04 PRELIMINARY REPORT OF A CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICIENCY OF NEOADJUVANT CAMRELIZUMAB AND APATINIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS: A PROSPECTIVE, PHASE II, SINGLE-ARM STUDY
por: Lin, Fuhua, et al.
Publicado: (2022)

Dual-energy spectral CT quantitative parameters for the differentiation of Glioma recurrence from treatment-related changes: a preliminary study
por: Lv, Yanchun, et al.
Publicado: (2020)

TIPS-13 A PHASE II STUDY OF NEOADJUVANT CAMRELIZUMAB AND APATINIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS
por: Guo, Chengcheng, et al.
Publicado: (2023)

TIPS-12 PHASE I CLINICAL STUDY OF TG02 CAPSULE IN THE TREATMENT OF RECURRENT HIGH-GRADE GLIOMAS WITH FAILED TMZ TREATMENT
por: Guo, Chengcheng, et al.
Publicado: (2023)

Comparison of diagnostic efficacy of (18)F-FDG PET/CT and (68)Ga-DOTANOC PET/CT in ectopic adrenocorticotropic hormone syndrome
por: Zhang, Bing, et al.
Publicado: (2022)

A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review
por: Muthukumar, Sankar, et al.
Publicado: (2022)

MRI combined with PET-CT of different tracers to improve the accuracy of glioma diagnosis: a systematic review and meta-analysis
por: Yang, Yihan, et al.
Publicado: (2017)

The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
por: Smits, Anja, et al.
Publicado: (2011)

Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis
por: Yang, Qunying, et al.
Publicado: (2021)

Outcome of surgical resection for brain metastases and radical treatment of the primary tumor in Chinese non–small-cell lung cancer patients
por: Li, Zhenye, et al.
Publicado: (2015)

Diagnostic accuracy of (13)N-ammonia PET, (11)C-methionine PET and (18)F-fluorodeoxyglucose PET: a comparative study in patients with suspected cerebral glioma
por: He, Qiao, et al.
Publicado: (2019)

Performance of Dual-tracer PET-CT for Staging Post–Liver Transplant Hepatocellular Carcinoma Recurrence
por: Au, Kin-Pan, et al.
Publicado: (2021)

IMG-02. VISUALIZATION OF TIGIT IN THE GLIOMA MICROENVIRONMENT: THE CREATION OF A PET IMAGING TRACER
por: Frederico, Stephen, et al.
Publicado: (2023)

A Diagnostic Nomogram Based on (18)F-FDG PET/CT for Bone Metastasis of Gastric Cancer
por: Wu, Chunhui, et al.
Publicado: (2021)

Microfluidics for Synthesis of Peptide-Based PET Tracers
por: Liu, Yang, et al.
Publicado: (2013)

Advanced Tracers in PET Imaging of Cardiovascular Disease
por: Li, Yesen, et al.
Publicado: (2014)

Adrenal tracer uptake by (18)F-FDOPA PET/CT in patients with pheochromocytoma and controls
por: Noordzij, Walter, et al.
Publicado: (2019)

(18)F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer
por: Rao, Liangjun, et al.
Publicado: (2016)

Chinese Erdheim-Chester disease: clinical-pathology-PET/CT updates
por: Ding, Huanyu, et al.
Publicado: (2015)

Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
por: Huang, Yuan, et al.
Publicado: (2021)

Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas
por: Li, Depei, et al.
Publicado: (2019)

A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis
por: Gormsen, Lars C., et al.
Publicado: (2016)

Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China
por: Xi, Shaoyan, et al.
Publicado: (2019)

Expression of CPEB4 in Human Glioma and Its Correlations With Prognosis
por: Hu, Wanming, et al.
Publicado: (2015)

Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Radiation Therapy Treatment Planning: A Review of PET Imaging Tracers and Methods to Incorporate PET/CT
por: Trotter, Jacob, et al.
Publicado: (2023)

GCT-30. TREATMENT OF PRIMARY INTRACRANIAL GERM CELL TUMORS: SINGLE INSTITUTION EXPERIENCE OF 74 CASES WITHOUT HISTOLOGICAL CONFIRMATION
por: Guo, Chengcheng, et al.
Publicado: (2020)

SYST-10 CSNO2012001 STUDY: A PHASE III TRIAL ON ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY WITH OR WITHOUT INTERFERON-ALPHA IN NEWLY DIAGNOSED HIGH-GRADE GLIOMAS
por: Chen, Zhongping, et al.
Publicado: (2022)

Using stable isotopes as tracer to investigate hydrological condition and estimate water residence time in a plain region, Chengdu, China
por: Zhou, Jing, et al.
Publicado: (2021)

Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes
por: Emsen, Berivan, et al.
Publicado: (2020)

Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT
por: Majala, Susanna, et al.
Publicado: (2019)

PET-CT for Evaluation of Spleen and Liver (18)F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma
por: Rao, Liangjun, et al.
Publicado: (2016)

LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis
por: Cai, Haiping, et al.
Publicado: (2020)

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
por: Li, Hongjia, et al.
Publicado: (2022)

Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications
por: Näslund, Olivia, et al.
Publicado: (2018)

Radiosynthesis and Preliminary Biological Evaluation of (18)F-Fluoropropionyl-Chlorotoxin as a Potential PET Tracer for Glioma Imaging
por: Zhao, Jing, et al.
Publicado: (2018)

Prognostic implications of dual tracer PET/CT: PSMA ligand and [(18)F]FDG PET/CT in patients undergoing [(177)Lu]PSMA radioligand therapy
por: Michalski, Kerstin, et al.
Publicado: (2020)

PET Tracers for Clinical Imaging of Breast Cancer
por: Peñuelas, Iván, et al.
Publicado: (2012)

Stroke detection with 3 different PET tracers
por: Dundar, Ayca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7ku4k3illj0476r17g02s539u7